Brief: Brazil's Biomm Signs Exclusive Agreement With Huisheng Biopharmaceutical To Sell, Distribute Insulin Degludec in Brazil
02/05/2024 22:19
May 2 (Reuters) - Huisheng International Holdings Ltd
1340.HK :
* IT SIGNED AN EXCLUSIVE AGREEMENT WITH HUISHENG
BIOPHARMACEUTICAL
CO TO SELL, DISTRIBUTE INSULIN DEGLUDEC - FILING
* AGREEMENT WITH HUISHENG BIOPHARMACEUTICAL CO TO ENCOMPASS
BRAZILIAN TERRITORY
Source text for Eikon: ID:nNS0N3GQ05
Further company coverage: 1340.HK
(Reporting by Sao Paulo newsroom)
((Andre.Romani@thomsonreuters.com;))
Recent news on Huisheng International Holdings
See all newsBrief: Huisheng International To Issue 11 Million Shares At HK$0.48 Each Under General Mandate
Brief: Huisheng International Proposes Share Consolidation Of Every 8 Shares Into 1 Share
Brief: Huisheng International Says Xiang Yuan Appointed Executive Director
Brief: Huisheng International Appoints Zhang Zhenghua As Executive Director
Brief: Brazil's Biomm Signs Exclusive Agreement With Huisheng Biopharmaceutical To Sell, Distribute Insulin Degludec in Brazil